ArticleArchives of endocrinology and metabolism2026
Assessment of body composition, quality of life, and depression in women with polycystic ovary syndrome.
Article in Archives of endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polyendocrine metabolic ovarian syndrome - a new name for an old problem.Nature metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate body composition, quality of life, and depression risk in women with polycystic ovary syndrome (PCOS) compared to women without PCOS. SUBJECTS AND
methodsThis prospective, cross-sectional study assessed quality of life (QoL) and depressive symptoms in women with polycystic ovary syndrome (PCOS) compared with controls with and without overweight or obesity. Assessments included body composition, QoL, health-related quality of life (HRQoL), and depressive symptoms. Participants without PCOS were divided into two groups according to BMI: < 25 kg/m2 [median age 30 years (27-33)] and ≥ 25 kg/m2 [median age 32 years (29-35)].
resultsThe study included 47 women with polycystic ovary syndrome (PCOS) phenotypes A and B. The median age was 29 years (25-35), and the median body mass index (BMI) was 32.08 kg/m2 (28.48-36.40). Women with PCOS showed a higher risk of depression (24% with moderate to severe risk) compared with women without PCOS, both with and without overweight or obesity (5% and 3%, respectively). Additionally, women with PCOS consistently reported lower QoL and HRQoL scores, particularly in the physical, environmental, and overall QoL domains, as well as in functional capacity, pain, general health status, vitality, emotional well-being, and mental health domains of HRQoL.
conclusionBased on these findings, we concluded that body composition does not appear to be a determining factor for increased risk of depressive symptoms or poorer perceptions of QoL and HRQoL in women with PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.